Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

A group of Boston-area health institutions, known as the Boston Autologous Islet Replacement Program, are teaming up to develop, test and deploy stem cells to cure diabetes. The group includes the Harvard Stem Cell Institute, Brigham and Women's Hospital, the Joslin Diabetes Center, Dana-Farber Cancer Institute and Semma Therapeutics. The innovation began when Doug Melton, Co-Director …

Continue reading Harvard Stem Cell Institute Teaming Up to Develop Diabetes Cure

MBBP Client Valeritas, Inc. Announced Positive Results for V-Go® Disposable Insulin Delivery Device

MBBP client Valeritas, Inc. has recently announced positive results for four studies on their flagship product. Valeritas is a commercial-stage medical technology company focused on developing innovative solutions to improve health and quality of life of people with Type 2 diabetes. Their flagship product is the V-Go® Disposable Insulin Delivery Device which is a small, wearable, disposable insulin delivery solution for …

Continue reading MBBP Client Valeritas, Inc. Announced Positive Results for V-Go® Disposable Insulin Delivery Device

MBBP Client Valeritas Files IPO

On February 12, 2015, MBBP client Valeritas, Inc., a medical technology company focused on the development and commercialization of innovative drug delivery solutions, filed for a $90 million IPO. The filing with the SEC arrives one week after insulin pump maker Asante Solutions postponed its proposed $49 million offering. Valeritas markets a disposable device that …

Continue reading MBBP Client Valeritas Files IPO